Amgen Inc (AMGN)
305.76
+0.05
(+0.02%)
USD |
NASDAQ |
Mar 27, 16:00
305.76
0.00 (0.00%)
After-Hours: 20:00
Amgen Max Drawdown (5Y): 24.86% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Gilead Sciences Inc | 38.10% |
| Johnson & Johnson | 27.36% |
| Eli Lilly and Co | 24.27% |
| Regeneron Pharmaceuticals Inc | 44.76% |
| Viking Therapeutics Inc | 89.26% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 2.369 |
| Beta (5Y) | 0.5271 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.66% |
| Historical Sharpe Ratio (5Y) | 0.4188 |
| Historical Sortino (5Y) | 0.914 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 8.63% |